Literature DB >> 3970930

Reduced ribosomal binding of eukaryotic elongation factor 2 following ADP-ribosylation. Difference in binding selectivity between polyribosomes and reconstituted monoribosomes.

O Nygård, L Nilsson.   

Abstract

The biological activity of elongation factor 2 (EF-2) following NAD+ - and diphtheria-toxin-dependent ADP-ribosylation was studied (i) in translation experiments using the reticulocyte lysate system and (ii) in ribosomal binding experiments using either reconstituted empty rat liver ribosomes or programmed reticulocyte polysomes. Treatment of the lysates with toxin and NAD+ at a NAD+/ribosome ratio of 4 resulted in a 90% inhibition of the amino acid incorporation rate. The inhibition was overcome by the addition of native EF-2. At this level of inhibition more than 90% of the EF-2 present in the lysates was ADP-ribosylated and the total ribosome association of EF-2 was reduced by approx. 50%. All of the remaining unmodified factor molecules were associated with the ribosomes, whereas only about 3% of the ribosylated factor was ribosome-associated. The nucleotide requirement for the binding of EF-2 to empty reconstituted rat liver ribosomes and programmed reticulocyte polysomes was studied together with the stability of the resulting EF-2 X ribosome complexes using purified 125I-labelled rat liver EF-2. With both types of ribosomes, the complex formation was strictly nucleotide-dependent. Stable, high-affinity complexes were formed in the presence of the non-hydrolysable GTP analogue guanosine 5'-(beta, gamma-methylene)triphosphate (GuoPP[CH2]P). In contrast to the reconstituted ribosomes, GTP stimulated the formation of high-affinity complexes in the presence of polysomes, albeit at a lower efficiency than GuoPP[CH2]P. The formation of high-affinity complexes was restricted to polysomes in the pretranslocation phase of the elongation cycle. Low-affinity post-translocation complexes, demonstrable after fixation, were formed in the presence of GTP, GuoPP[CH2]P and GDP. In polysomes, these complexes involved a different population of particles than did the high-affinity complexes. In the binding experiments using reconstituted or programmed ribosomes, the pretranslocation binding of EF-2 observed in the presence of GuoPP[CH2]P was reduced by approx. 50% after ADP-ribosylation, whereas the post-translocation binding in the presence of GDP was unaltered. The data indicate that the inhibition of translocation caused by diphtheria toxin and NAD+ is mediated through a reduced affinity of the ADP-ribosylated EF-2 for binding to ribosomes in the pretranslocation state.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3970930     DOI: 10.1016/0167-4781(85)90092-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

1.  Truncated elongation factor G lacking the G domain promotes translocation of the 3' end but not of the anticodon domain of peptidyl-tRNA.

Authors:  C Borowski; M V Rodnina; W Wintermeyer
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

2.  Eukaryotic elongation factor 2 can bind to the synthetic oligoribonucleotide that mimics sarcin/ricin domain of rat 28S ribosomal RNA.

Authors:  S Tang; W J He; H Xu; W Y Liu; K C Ruan
Journal:  Mol Cell Biochem       Date:  2001-07       Impact factor: 3.396

3.  Three-dimensional structure of the ribosomal translocase: elongation factor G from Thermus thermophilus.

Authors:  A AEvarsson; E Brazhnikov; M Garber; J Zheltonosova; Y Chirgadze; S al-Karadaghi; L A Svensson; A Liljas
Journal:  EMBO J       Date:  1994-08-15       Impact factor: 11.598

Review 4.  PARPs and ADP-ribosylation in RNA biology: from RNA expression and processing to protein translation and proteostasis.

Authors:  Dae-Seok Kim; Sridevi Challa; Aarin Jones; W Lee Kraus
Journal:  Genes Dev       Date:  2020-02-06       Impact factor: 11.361

Review 5.  MARTs and MARylation in the Cytosol: Biological Functions, Mechanisms of Action, and Therapeutic Potential.

Authors:  Sridevi Challa; MiKayla S Stokes; W Lee Kraus
Journal:  Cells       Date:  2021-02-03       Impact factor: 6.600

6.  Modes of action of ADP-ribosylated elongation factor 2 in inhibiting the polypeptide elongation cycle: a modeling study.

Authors:  Kevin C Chen; Honglin Xie; Yujie Cai
Journal:  PLoS One       Date:  2013-07-08       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.